CD274 and cancer: As a result, 2-DG can not only reduce cell surface PD-L1 expression by downregulating the glycosylation of PD-L1, but can also deglycosylate the PARPi-generated PD-L1 protein in TNBC to induce the cancer cells more susceptible to T-cell-mediated death.